Abstract
Background:
Repetitive transcranial magnetic stimulation (rTMS) modulates cortical excitability and facilitates motor learning to improve motor recovery after stroke. Action observation (AO) therapy effectively facilitates physical training for motor memory formation.
Objective:
To compare the effectiveness of rTMS alone with that of combined rTMS and AO for the functional recovery of upper extremity function in subacute stroke patients and to verify the safety of the interventions.
Methods:
The present study was a prospective, randomized controlled trial involving subacute unilateral stroke patients. In total, 22 patients were randomly assigned to 2 groups: the trial group (rTMS with AO) and the control group (rTMS alone). Both groups received 1 Hz rTMS (intensity: 120% of resting motor threshold; rMT) over the contralesional primary motor cortex for 20 minutes on 10 consecutive days. Trial group received rTMS while watching a video of 5 different complex hand movements. The functional parameters were the Brunnstrom stage, Fugl-Meyer assessment (FMA) score of the upper extremity, Manual Function Test (MFT) score, and grip power. The following motor evoked potential (MEP) parameters were recorded from the abductor pollicis brevis muscle: rMT, latency, and amplitude. Both parameters were measured before and after the 2 week intervention.
Results:
After the 2 week trial, the total FMA and MFT scores were significantly improved in both groups, but the MFT subscores of hand motor function and grip power were significantly improved in the combination therapy group only. In contrast, the changes (Δ) of FMA, MFT, grip power test, and MEP outcomes were not significantly different between the 2 groups. No adverse events or complications were reported.
Conclusions:
Distal upper extremity function, as measured by MFT and grip power, was improved after rTMS and AO in combination. The combination of rTMS with AO may be applied safely to improve upper extremity function after stroke.
Introduction
Stroke is the leading cause of physical disability worldwide (Ward, 2005). About one-third of stroke survivors suffer severe motor deficits in the acute stage, and half are left with some degree of physical impairment (Bonita & Beaglehole, 1988). Characteristics of motor impairment across patients are diverse and include a range of functional ability and recovery (Carey, Abbott, Egan, Bernhardt, & Donnan, 2005). Weaknesses can affect all muscle groups in the upper extremities, or may be selective, affecting some muscle groups more than others. Previous research has shown that no consistency in proximal-to-distal or flexor-to-extensor weakness gradient exists (Raghavan, 2015; Tyson, Chillala, Hanley, Selley, & Tallis, 2006).
To treat motor weakness after stroke, various neuro-rehabilitative therapies have been suggested. For example, previous researchers have found that the motor areas of the human brain are recruited by mental rehearsal or simple observation, as well as by actual execution (Jeannerod, 2001). Thus, action observation (AO) therapy facilitates physical training for motor memory formation (Celnik, Webster, Glasser, & Cohen, 2008). AO is based on mirror neurons, which were first described in monkeys (Gallese, Fadiga, Fogassi, & Rizzolatti, 1996; Rizzolatti, Fadiga, Gallese, & Fogassi, 1996). Gallese et al. described a set of F5 neurons in monkeys that became active both when the animal performed a specific action and when it watched a similar action being performed by a human. The researchers named these “mirror neurons.” Thereafter, homologous F5 neurons have been sought in the human brain. One study using brain functional magnetic resonance imaging (fMRI) suggested that 1 mirror neuron circuit in humans is located in the inferior parietal lobule, a posterior part of the inferior frontal gyrus and adjacent premotor cortex (Buccino et al., 2004). Measured motor evoked potentials (MEPs) showed significant modulation of the observers’ corticospinal system while they watched a man lifting an object. The response differed depending on the objects’ weight and grip patterns indicating that the effect on the brain may depend on the extent of observation and the content being observed (Lapenta, Ferrari, Boggio, Fadiga, & D’Ausilio, 2018; Senot et al., 2011). Furthermore, AO with a fixed point-of-gaze facilitated higher MEP amplitudes than free viewing; thus, directing the observers’ gaze during AO may optimize acquisition (D’Innocenzo, Gonzalez, Nowicky, Williams, & Bishop, 2017).
Brain areas may undergo maladaptive plasticity after stroke, affecting both neural activation and motor behavior. In this regard, rTMS may modulate cortical excitability, and thus, facilitate motor learning and improve motor recovery (Du et al., 2016; Le, Qu, Zhu, Tao, & Li, 2013; Tosun et al., 2017). This non-invasive technique applies focused magnetic stimulation to the skull to target a particular brain area. In healthy adults, low-frequency (<1 Hz) rTMS can suppress cortical excitability, resulting in an inhibiting motor cortex, whereas at higher frequencies (>5 Hz), rTMS can induce long-term potentiation facilitating it (Askin, Tosun, & Demirdal, 2017). Therapeutic utility of TMS has been explored in many conditions with varying degrees of success for psychiatric disorders, such as major depressive disorder, drug addiction, eating disorders, or obesity; neurologic diseases such as Parkinson’s disease or epilepsy; rehabilitation of aphasia or dysphagia after stroke; and pain associated diseases, such as neuropathic pain or migraine (Dosenovic et al., 2017; Ilkhani, Shojaie Baghini, Kiamarzi, Meysamie, & Ebrahimi, 2017; Lefaucheur et al., 2014; Loo & Mitchell, 2005; Nardone et al., 2017; Noohi & Amirsalari, 2016; Song, Zilverstand, Gui, Li, & Zhou, 2018; Stilling, Monchi, Amoozegar, & Debert, 2019; Tarameshlu, Ansari, Ghelichi, & Jalaei, 2019; Yang et al., 2018).
Recently extensive literature has analyzed the effects of AO with rTMS in healthy participants. Continuous theta burst stimulation to the left inferior parietal lobule before mental rehearsal of motor tasks decreased reaction time for the implicit and random sequences in healthy participants (Kraeutner, Keeler, & Boe, 2016). Furthermore, inhibitory rTMS on the left dorsal premotor cortex decreased the success rate of action prediction in healthy participants (Brich, Bachle, Hermsdorfer, & Stadler, 2018). However, few studies have addressed the effect of combined rTMS and AO in subacute stroke patients.
In the present study, we hypothesized that the brain modulating effects of the conventional inhibitory rTMS protocol (usually 20 minutes) and AO are amplified and facilitated when combined. Therefore, we investigated whether combined rTMS and AO therapy is superior to rTMS therapy alone in terms of alleviating motor impairment in subacute stroke patients, as measured using standard functional scales and MEP parameters. We also recorded any adverse events during the study.
Materials and methods
Participants
This single-center, prospective, randomized controlled study was conducted in subacute stroke survivors who were referred to subacute rehabilitation units after acute stroke between September 2012 and August 2013.
The inclusion criteria were as follows: (1) age 18 years or older, (2) first ever stroke, (3) unilateral vascular stroke lesion in the cerebral hemisphere, as confirmed by computed tomography (CT) or magnetic resonance imaging (MRI), (4) mild-to-moderate unilateral hemiparesis secondary to cerebrovascular accident (finger movements of more than fair grade and individual finger movement possible), (5) ability to follow simple verbal commands or instructions (no severe deficit in visual, attentional, or language comprehension), (6) MEP response test performed in the paralyzed hand (patients were excluded when a TMS of 100% intensity failed to induce MEP response). The exclusion criteria were as follows: (1) bilateral cerebral hemisphere lesion, (2) brain stem lesion, (3) known history of previous stroke, (4) cognitive impairment that prevented compliance with test instructions, (5) presence of unstable medical conditions, (6) peripheral neuropathy that could have affected MEP response, and (7) contraindications to TMS (seizure, cardiac pacemaker, or coil embolization).
The G*Power program (v3.1.9.2; Franz Faul, Kiel University, Germany) was used to calculate the necessary sample size of the test subjects. Based on a previous study using 1 Hz rTMS on the paretic hand of patients who had suffered chronic stroke, an effect size of 0.97 was selected (Takeuchi et al., 2008; L. Zhang, Xing, Fan, et al., 2017). In the Mann-Whitney U test, a α-error of 0.05 and a β of 0.20 (power level of 0.80) were used. The results showed that the control and experimental groups required at least 10 patients each. Assuming a dropout rate of 10%, at least 11 patients were needed in each group.
A total of 122 stroke survivors were admitted to the rehabilitation unit of the Department of Physical Medicine and Rehabilitation at Korea University Anam Hospital during the study period. They were screened for eligibility using the inclusion criteria. A CONSORT diagram (Fig. 1) shows the study flow chart. Two patients declined to continue the study, citing economic reasons and a mild headache during the pre-interventional MEP study. Therefore, 22 patients were assigned to the trial group (n = 11) and the control group (n = 11).
Flowchart of participant selection. Abbreviations: rTMS, repetitive transcranial magnetic stimulation; AO, action observation.
The study was approved by Clinical Research Information Service (CRIS) (KCT0003200) and the Institutional Review Board of Korea University Anam Hospital (AN12030-002). All patients submitted written informed consent for study participation. The current study was conducted in accordance with the Declaration of Helsinki.
Patients were identified by a number assigned by a centralized computer-generated randomization code. The patients were randomly allocated to 1 of the following 2 groups: (1) combined rTMS and AO group (trial group) or (2) rTMS alone (control group). All subjects underwent conventional physical and occupational therapy, including range of motion and strengthening exercises, gait and balance training, manual dexterity exercises, and activities of daily living (ADL) training for 1 hour twice a day (5 days/week).
Motor evoked potentials (MEP) study
Before and after the 2 week rTMS treatment, MEPs were recorded in the abductor pollicis brevis (APB) muscle by a blinded rater. The resting motor threshold (rMT) was assessed using the method described in the study by Rossini et al., which was used in previous studies (Khedr, Ahmed, Fathy, & Rothwell, 2005; Rossini et al., 1994). An elastic cap was put on each patient’s head and placed using standard anatomical markers along the nasion-to-inion line and the interaural line. The coil was kept tangential to the scalp and maintained at 45° to the mid-sagittal line. The “hot spot” was defined as the point at which the MEP amplitude, elicited with supramaximal threshold intensity in the APB muscle, was the highest. MEP amplitude was measured between the 2 largest peaks of opposite polarity (Day et al., 1987; Rothwell, Day, Berardelli, & Marsden, 1984). If no opposite polarity was detected, we considered it unobtainable. Once the optimal scalp location (“hot spot”) had been determined, a single TMS pulse was delivered to the location to identify the rMT, defined as the minimum intensity capable of producing at least 5 MEPs of > 50μV in 10 consecutive trials. The stimulation was delivered using a figure-of-eight coil and a MagPro×100 magnetic stimulator (MagVenture Ltd., Reading, United Kingdom).
Repetitive transcranial magnetic stimulation
The magnetic stimulus protocol and stimulation intensity of rTMS were the same as reported in a study by Emara, and the stimulation duration was 20 minutes (Emara et al., 2010). Both groups received 1 Hz rTMS (intensity: 120% of rMT) over the contralesional “hot spot”, the hand area of the motor cortex on 10 consecutive weekdays. The duration of the trains of rTMS was within the safe range described by the Safety of TMS Consensus Group (Rossi, Hallett, Rossini, & Pascual-Leone, 2009). The rTMS intervention was performed just before the subjects underwent conventional occupational therapies. Subjects were instructed to sit in a comfortable chair in a relaxed position, with both hands placed on its armrests, and to stay awake during the procedure. The stimulation induced a response in the APB muscle, which manifested as a muscle twitch that was recorded as an MEP using surface electromyography in the affected upper extremity. The rTMS was delivered using the same MagPro ×100 magnetic stimulator as mentioned above.
Action observation
To perform AO, videos were prepared featuring an able-bodied individual. Trial group received rTMS intervention while watching the video on a 19 inch monitor positioned 1 meter in front of them in a quiet room. The video displayed 5 different complex hand movements: 1) lifting up a white baseball by about 10 cm with the fingers spread out and then the subsequent downward motion, 2) moving 5 gray cans 1 by 1 in line with the fence on the table, 3) flipping yellow cards (15 cm horizontal, 10 cm vertical) over vertically 1 by 1, 4) stacking button-shaped objects 4 cm in length and 1 cm in height vertically, 5) and putting small objects (2 clips, bottle caps and coins) into a large can. These actions were derived from the evaluation items from the Jebsen Hand Function Test. Each video clip was 2 minutes long, and all videos were repeated in sequence for a total running time of 20 minutes. Control group received rTMS treatment but were not provided with any visual materials. The rTMS and AO interventions were delivered by a physiatrist who was otherwise uninvolved in the present study.
Outcome measures
The outcome measures were upper extremity motor function and neurophysiologic parameters representing motor cortical excitability, as determined using MEP. These were measured before and after completion of the 2 week treatment by an assessor who was otherwise uninvolved in the present study. To assess upper extremity function, we determined the Brunnstrom stage and the Fugl-Meyer assessment (FMA) score of the upper extremity; we also carried out the Jebsen Hand Function test, manual function test (MFT), and grip power test using a dynamometer. The Jebsen Hand Function test results were ultimately excluded from the analysis because many patients failed to perform the test items. The manual function test (MFT) evaluates arm and hand function; its validity and reliability have been verified in stroke patients (H. J. Kim et al., 2017; Miyamoto, Kondo, Suzukamo, Michimata, & Izumi, 2009; Sone et al., 2015). The MFT has 4 items that evaluate the function of the shoulder as the proximal part of the upper limb (forward elevation of the upper limb, lateral elevation of the upper limb, touching the occiput with the palm, and touching the back with the palm) and 4 items that evaluate the hand as the distal part of the upper limb (grasping, pinching, carrying cubes, and manipulating a pegboard). The total possible MFT score across the 8 tasks is 32 (0 indicates severely impaired function and 32 indicates full function).
The neurophysiological parameters measured by MEP were rMT, latency, and amplitude; 120% of the rMT intensity was used to evoke motor responses in the APB, and the onset latency and peak-to-peak amplitude of the motor response were measured for analysis.
Statistical analysis
Independent t test and Fisher’s exact test were used to compare parametric and nonparametric data at baseline between the 2 groups. The Shapiro-wilt test was used to test normality of the data. Nonparametric statistics were used because the measures did not follow a normal distribution. The before-and after-treatment results of the clinical outcomes and MEP parameters were analyzed using the Wilcoxon signed-rank test in each group. Changes in functional outcome and MEP parameters at the 2-week follow-up evaluation were compared between the 2 groups using the Mann–Whitney U test. All statistical analyses were performed using SPSS version 22.0 for Windows (SPSS Inc., Chicago, IL, USA). All p-values <0.05 were considered statistically significant. For reducing the risk of Type-I error in the statistical analyses, adjustments were made using the Bonferroni method for multiple comparisons between the trial and control groups.
Results
Baseline characteristics of participants
Baseline characteristics of participants
Abbreviations: rTMS, repetitive transcranial magnetic stimulation; AO, action observation; M, male; F, female; K-MMSE, Korea mini mental state examination.
After the 2 week rTMS intervention, both groups demonstrated significant gains in upper extremity functional parameters, as measured by FMA and MFT (Fig. 2). The total MFT score, as well as the proximal limb subscore, was significantly improved in both groups. However, the subscore of the distal limb was significantly improved in the trial group only (Fig. 2). Similarly, grip power showed significant improvement in the control group. No significant changes were noted in all the MEP parameters after rTMS intervention, except for increase in rMT in the control group (Table 2).

Fugl-Meyer assessment, manual function test (total), and manual function test (distal) results of each participant and its average before and after intervention. X axis represents the participant number while Y axis represents the test results. Abbreviations: rTMS, repetitive transcranial magnetic stimulation; AO, action observation; FMA, Fugl-Meyer assessment; MFT, manual function test; *,<0.05; -, score of zero.
Before-and after-treatment results of the clinical outcomes and MEP parameters in trial and control groups
Abbreviations: SD, standard deviation; IQR, interquartile range; FMA, Fugl-Meyer assessment; MFT, manual function test; MEP, motor evoked potential; rMT, resting motor threshold; *, p < 0.05.
Table 3 and Fig. 3 compare the changes (Δ) in clinical and MEP parameters between the trial group and the control group. The changes in clinical outcomes showed no significant difference between the groups. Similarly, MEP parameters (rMT, latency, amplitude) did not differ significantly between the 2 groups (p > 0.05/10) (Table 3).
Change in clinical and motor evoked potential parameters for individual participants between the trial and control groups. (A) Fugl-Meyer assessment (B) Manual function test (C) Grip power test (D) Resting motor threshold (contralesional) Abbreviations: rTMS, repetitive transcranial magnetic stimulation; AO, action observation; MEP, motor evoked potential; FMA, Fugl-Meyer assessment; MFT, manual function test; rMT, resting motor threshold. Differences in variables between trial and control groups Abbreviations: IQR, interquartile range; rTMS, repetitive transcranial magnetic stimulation; AO, action observation; FMA, Fugl-Meyer assessment; MFT, manual function test; MEP, motor evoked potential; rMT, resting motor threshold. A value of p < 0.005 (corresponding to p < 0.05 after adjusting for 10 independent tests by the Bonferroni correction) was considered significant.
The present study investigated whether the combined AO and traditional inhibitory rTMS protocol is superior to the rTMS protocol alone in terms of functional improvements in the upper extremities of stroke patients. After completion of a 2 week trial, the total FMA and MFT scores were significantly improved in both groups. However, the MFT subscores of hand motor function and grip power were significantly improved in the combination therapy group only. However, the post-therapy changes (Δ) did not differ significantly between the 2 groups.
Several studies have combined rTMS with other therapies to multiply the effects of the motor learning process. Finger motor tasks using numerical panels after rTMS and 10 minute ankle strengthening exercises before rTMS yielded significant improvements in motor performance (Kwon, Kim, Chang, Bang, & Shin, 2014; VanDerwerker et al., 2018). Conversely, task-specific occupational therapy, including stacking objects, opening jars, and eating finger foods immediately after rTMS or sham rTMS, showed no superiority to rTMS alone (Higgins, Koski, & Xie, 2013). More recently, virtual reality brain-computer interface training immediately after rTMS led to increased ipsilesional motor activity and improvements in behavioral function (Johnson et al., 2018). There have been several attempts to combine rTMS with other therapies. However, our intervention has an added advantage, because AO and rTMS can be carried out simultaneously. Previous studies have reported that both AO and rTMS have positive effects on motor recovery in stroke patients (Celnik et al., 2008; Cha & Kim, 2017; Lefaucheur, 2006). In particular, AO functions through the system of mirror neurons, a class of neural substrates that discharges during both AO and action execution (J. J. Q. Zhang, Fong, Welage, & Liu, 2018). Actions that are goal-oriented can activate mirror neuron systems and activate the motor learning process more effectively (Fadiga, Fogassi, Pavesi, & Rizzolatti, 1995). Furthermore, modulation of an observer’s motor system during observation may be supported by semantic information via a top-down mechanism (Senot et al., 2011).
Informed by previous studies, we tried to produce goal-oriented activities when creating the therapeutic AO video in the present study so that the patients could plan their behavior while watching. Considering that the effects of rTMS may diminish over time, this method is valuable. One TMS study found that MEP amplitude was depressed in the stimulated M1 by 20% immediately after rTMS, and that it returned to baseline 30 minutes later (Heide, Witte, & Ziemann, 2006). We expected that brain modulation would have a greater effect within the time window of the TMS when combined with AO. Although the changes in MFT score and grip power did not differ significantly between the groups, the results showed that distal upper extremity function improved significantly in the combination therapy group only, suggesting that the combination of AO and inhibitory rTMS facilitates recovery of hemiparetic hand function. Moreover, there were no reports of serious discomfort or other adverse events during the intervention, so this combined therapeutic intervention could be used to facilitate motor recovery in the upper extremities after stroke.
However, the results related to the Brunnstrom stage seemed to be inconsistent. A significant improvement was seen in the distal portions with regard to the Brunnstrom stage only in the control group. The return of hand function does not in every respect parallel the 6 recovery stages of the shoulder and elbow (Brunnstrom, 1966). Although the Brunnstrom stage is known to be correlated and well-responsive with respect to the evaluation of upper extremities in stroke patients (Safaz, Yilmaz, Yasar, & Alaca, 2009), it is a broad evaluation that is divided into only 6 categories and suitable for long-term follow-up. Thus, it may not have been sufficient to show changes in the patient group within 2 weeks, which might explain why the results were inconsistent. In this regard, we speculate that the longer the follow up, the better the results will be.
One unexpected finding of our study was the significant increase in contralesional rMT in the rTMS-only group. Shorter latency and higher amplitude of MEPs, shorter central motor conduction time, and diminished rMT are correlated with clinical measures evaluating motor functions in chronic stroke patients (Cakar et al., 2016). The exact time course of rMT after stroke is not well-known; however, it probably reduces over time after stroke but remains higher in the affected hemisphere with respect to that in the unaffected hemisphere at the chronic stage (Chipchase et al., 2012). A meta-analysis of inhibitory rTMS for stroke-induced upper limb motor deficit showed an enhancing effect on rMT in the unaffected hemisphere (L. Zhang, Xing, Shuai, et al., 2017). Nonetheless, in this study, contralesional rMT did not increase significantly in the trial group, and MEP latency and amplitude did not change significantly in either group. These results were probably due to a lack of homogeneity in the patient groups.
When cortical excitability changes in one hemisphere, it is modulated in homonymous regions of the contralesional hemisphere (Buetefisch, 2015). Intracortical disinhibition probably occurs due to impairment of the transcallosal fibers, and stroke patients exhibit unbalanced interhemispheric inhibition (Liepert, Hamzei, & Weiller, 2000; Sebastianelli et al., 2017). Inhibitory rTMS has been shown to restore the balance of interhemispheric inhibition after stroke (Heide et al., 2006). The optimal interval between stroke onset and rTMS is as yet unclear. However, several factors are alleged to influence the effect of rTMS. Stroke patients with younger age, exclusively subcortical lesion, mild motor impairment, and good functional status have shown superior upper limb recovery after rTMS (S. Y. Kim, Shin, Lee, Kim, & Hyun, 2016; Lee et al., 2015). Given that TMS has a greater effect in certain patient populations, a lack of homogeneity in the patient groups probably led to the inconsistent results in this study. Although we only recruited patients who had suffered unilateral stroke, the extent of descending motor pathway involvement would have been diverse. Therefore, further well-controlled studies are needed to investigate whether AO can reduce suppression of the contralesional hemisphere by inhibitory rTMS in a homogenous group of stroke patients.
This study had several limitations. Firstly, although we conducted a power calculation, the samples were diverse with regards to the extent and location of the lesions. These factors were not taken into account in the analysis. Secondly, we only observed the patients for a short period (2 weeks), so it will be necessary to compare the changes in latent effects in a long-term follow-up. Lastly, a control group of those who received conventional rehabilitation therapy for stroke without rTMS was not included in this study. Additionally, those who underwent rTMS but with a ‘sham’ type of stimulation and another control condition with ‘real’ stimulation on another scalp site (not on the motor cortex) would have generated more clear findings and demonstrated the site-specificity of the effects. Therefore, future studies involving more homogenous and larger cohorts with various methods of rTMS and longer duration will be needed to verify the efficacy of combined therapy.
Conclusions
In summary, our primary aim in this study was to elucidate the effect of combined rTMS and AO in patients following stroke. The intervention was conducted safely. The results showed that distal upper extremity function after therapy, as measured by MFT and grip power, was improved only in the trial group (rTMS with AO group) and not in the rTMS alone group. However, there was no significant difference in clinical outcomes between the 2 groups. The combination of rTMS with AO may be a safe intervention to improve upper extremity function after stroke. The long-term benefits of this combination therapy and deciding an appropriate target group should be investigated in future studies.
Footnotes
Acknowledgments
No potential conflict of interests relevant to this article were reported. This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2019R1A2C2003020).
